UiPath, Inc.: Form 10-Q for the period ended Jul 31, 2021
Filed with the SEC on Sep 8, 2021 and accepted by EDGAR at Sep 8, 2021, 17:26 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-05-01 to 2021-07-31 | $195.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2021-02-01 to 2021-07-31 | $381.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2021-05-01 to 2021-07-31 | $35.6m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2021-02-01 to 2021-07-31 | $84.6m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2021-05-01 to 2021-07-31 | $159.9m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-02-01 to 2021-07-31 | $297.1m | us-gaap:GrossProfit |
| Research and development | 3 months2021-05-01 to 2021-07-31 | $57.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-02-01 to 2021-07-31 | $150.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-05-01 to 2021-07-31 | −$97.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-02-01 to 2021-07-31 | −$333.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2021-05-01 to 2021-07-31 | $1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-02-01 to 2021-07-31 | $3.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-05-01 to 2021-07-31 | −$100.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-02-01 to 2021-07-31 | −$339.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-05-01 to 2021-07-31 | −$0.19 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-02-01 to 2021-07-31 | −$0.91 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-05-01 to 2021-07-31 | −$0.19 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-02-01 to 2021-07-31 | −$0.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-05-01 to 2021-07-31 | 526,512,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-02-01 to 2021-07-31 | 373,488,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-02-01 to 2021-07-31 | −$23.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-02-01 to 2021-07-31 | $3.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-07-31 | $1.83bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-07-31 | $2.16bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-07-31 | $2.35bn | us-gaap:Assets |
| Current liabilities | At period end2021-07-31 | $374.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-07-31 | $448.9m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-07-31 | $1.90bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001734722-21-000009. Last ingested by Listed: Oct 26, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.